Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Connect with industry professionals using effective methods. Discover ways to enhance your network and open new opportunities.
16,127 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
U.S. airlines regain pricing power as fares rise 15-20%. Delta's Q2 results bolster the view that premium demand supp...
As AI evolves, investors face a choice: a defense-first, multi-year government play or a fast-growing consumer voice ...
In a year marked by mixed silver signals, investors are weighing two distinct paths: the cash-flow stability of SIL v...
As markets rally into mid-2026, analysts spotlight five stock setups where Wall Street sees the most upside, driven b...
MassMutual CEO Roger Crandall frames the mounting debt burden as a daily drag on households and long-term growth. The...
Cornerstone Capital Bank expands its retail mortgage footprint by adding The Wizelman Team led by veteran lender Dary...
Morgan Stanley's latest bottom up view argues that AI infrastructure demand will outpace supply, turning the Nebius s...
Brussels unveiled rules forcing Google to share search data with rival services and open Android to competitor AI dev...
AI growth hinges on advanced chips, and Taiwan Semiconductor Manufacturing sits at the center. This article breaks do...
Air-taxi darlings Joby, Archer, and EHang have fallen sharply in 2026 as cert timelines and cash burn loom large. Inv...
Regulators are steering crypto away from its Wild West image. This shift could unlock real advantages for XRP, from c...